O'Sullivan-McLeod syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:99965G12.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

O'Sullivan-McLeod syndrome is a rare, slowly progressive form of spinal muscular atrophy (also classified under distal hereditary motor neuronopathy) that predominantly affects the small muscles of the hands. First described by O'Sullivan and McLeod in 1978, this condition is characterized by progressive wasting and weakness of the thenar and hypothenar muscles (the muscles at the base of the thumb and little finger), as well as the intrinsic hand muscles, leading to difficulty with fine motor tasks such as gripping, writing, and manipulating small objects. The condition primarily affects the lower motor neurons that innervate the distal upper extremities, and it is notable for its very slow progression and relatively benign course compared to other motor neuron diseases. The syndrome typically presents in young adulthood, most commonly in women, and is distinguished from other forms of spinal muscular atrophy by its restriction to the hands and distal upper limbs, with little or no involvement of the lower extremities or proximal muscles. Sensory function is preserved, and there are no upper motor neuron signs, distinguishing it from amyotrophic lateral sclerosis (ALS). Electromyography (EMG) typically shows chronic denervation changes in the affected hand muscles, while nerve conduction studies remain relatively normal, confirming the motor neuron origin of the disease. There is currently no curative treatment for O'Sullivan-McLeod syndrome. Management is supportive and focuses on occupational therapy to maintain hand function, adaptive devices to assist with daily activities, and regular neurological monitoring to track disease progression. The prognosis is generally favorable, as the disease tends to progress very slowly and does not significantly affect life expectancy. The underlying genetic cause has not been definitively established, and many cases appear to be sporadic.

Clinical phenotype terms— hover any for plain English:

Intrinsic hand muscle atrophyHP:0008954Hand muscle weaknessHP:0030237Atrophy of the spinal cordHP:0006827Cold paresisHP:0031372Hyperintensity of MRI T2 signal of the spinal cordHP:0040272
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for O'Sullivan-McLeod syndrome.

View clinical trials →

No actively recruiting trials found for O'Sullivan-McLeod syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the O'Sullivan-McLeod syndrome community →

No specialists are currently listed for O'Sullivan-McLeod syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to O'Sullivan-McLeod syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open O'Sullivan-McLeod syndromeForum →

No community posts yet. Be the first to share your experience with O'Sullivan-McLeod syndrome.

Start the conversation →

Latest news about O'Sullivan-McLeod syndrome

No recent news articles for O'Sullivan-McLeod syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about O'Sullivan-McLeod syndrome

What is O'Sullivan-McLeod syndrome?

O'Sullivan-McLeod syndrome is a rare, slowly progressive form of spinal muscular atrophy (also classified under distal hereditary motor neuronopathy) that predominantly affects the small muscles of the hands. First described by O'Sullivan and McLeod in 1978, this condition is characterized by progressive wasting and weakness of the thenar and hypothenar muscles (the muscles at the base of the thumb and little finger), as well as the intrinsic hand muscles, leading to difficulty with fine motor tasks such as gripping, writing, and manipulating small objects. The condition primarily affects the

How is O'Sullivan-McLeod syndrome inherited?

O'Sullivan-McLeod syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does O'Sullivan-McLeod syndrome typically begin?

Typical onset of O'Sullivan-McLeod syndrome is adult. Age of onset can vary across affected individuals.